ARCHIVES

ODAC Meets at ASCO, Recommends Approval Of Dasatinib For CML.

This article is from The Cancer Letter archive.

Vol. 32 No. 22 | June 9, 2006

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities: CAM Research Center Applications Sought.

January 3, 2003

ASCO Conquer Cancer Foundation Awards $6 Million To Researchers

April 22, 2011

Smoking, Drinking Factors Affect Adherence to Preventive Regimen

September 30, 2011

ONS Backs Independent Nursing Research, Splits From ASCO On Meetings

September 3, 1982

LabCorp Marketing Of Ovarian Cancer Test Unlawful, FDA Says In Warning Letter.

October 17, 2008

IOM Panel: NCI Clinical Trials Groups At “Breaking Point,” More Funds Needed.

April 16, 2010